financetom
Business
financetom
/
Business
/
Charles Schwab profit surges on trading boom, asset growth
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Charles Schwab profit surges on trading boom, asset growth
Jul 18, 2025 6:23 AM

(Reuters) -U.S. brokerage firm Charles Schwab said on Friday its profit rose nearly 60% in the second quarter, driven by robust trading activity and increased asset management fees.

Shares of Charles Schwab, which have gained nearly 26% in 2025, rose 2.5% in premarket trading.

Market uncertainty from President Trump's broad tariff measures sparked heightened volatility earlier this year, driving investors to actively rebalance portfolios and boosting trading revenue at firms like Charles Schwab.

Trading revenue at the company came in at $952 million in the second quarter compared to $777 million in the year earlier.

A late-quarter market rebound not only lifted assets under management at brokerages but also enabled firms like Schwab to collect higher fees.

The Westlake, Texas-based company's total client assets rose 14% to a record $10.76 trillion.

Its asset management and administration fees, earned from managing mutual funds and exchange-traded funds, jumped 13.5% to $1.57 billion.

Charles Schwab's net income came in at $2.13 billion, or $1.08 per share, for the three months ended June 30, compared with $1.33 billion, or 66 cents per share, in the year-ago quarter.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Copyright 2023-2026 - www.financetom.com All Rights Reserved